Cargando…
TuberQ: a Mycobacterium tuberculosis protein druggability database
In 2012 an estimated 8.6 million people developed tuberculosis (TB) and 1.3 million died from the disease [including 320 000 deaths among human immunodeficiency virus (HIV)-positive people]. There is an urgent need for new anti-TB drugs owing to the following: the fact that current treatments have s...
Autores principales: | Radusky, Leandro, Defelipe, Lucas A., Lanzarotti, Esteban, Luque, Javier, Barril, Xavier, Marti, Marcelo A., Turjanski, Adrián G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014675/ https://www.ncbi.nlm.nih.gov/pubmed/24816183 http://dx.doi.org/10.1093/database/bau035 |
Ejemplares similares
-
Target-Pathogen: a structural bioinformatic approach to prioritize drug targets in pathogens
por: Sosa, Ezequiel J, et al.
Publicado: (2018) -
An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets
por: Radusky, Leandro G, et al.
Publicado: (2015) -
Aromatic clusters in protein–protein and protein–drug complexes
por: Lanzarotti, Esteban, et al.
Publicado: (2020) -
Protein Topology Determines Cysteine Oxidation Fate: The Case of Sulfenyl Amide Formation among Protein Families
por: Defelipe, Lucas A., et al.
Publicado: (2015) -
Solvents to Fragments to Drugs: MD Applications in Drug Design
por: Defelipe, Lucas A., et al.
Publicado: (2018)